Liabilities and Equity in USD of NKGen Biotech, Inc. from Q1 2021 to Q4 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary: NKGen Biotech, Inc. quarterly Liabilities and Equity history and change rate from Q1 2021 to Q4 2024.
NKGen Biotech, Inc. Liabilities and Equity for the quarter ending 31 Dec 2024 was $16,231,000, a 1.5% decline year-over-year.
Source SEC data: View on sec.gov

Liabilities and Equity, Quarterly (USD)

Liabilities and Equity, YoY Quarterly Change (%)

NKGen Biotech, Inc. Quarterly Liabilities and Equity (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2024	$16,231,000	-$250,000	-1.5%	31 Dec 2024	10-K	08 Oct 2025	2024	FY
Q3 2024	$14,995,000	-$10,203,000	-40%	30 Sep 2024	10-Q	04 Mar 2025	2024	Q3
Q2 2024	$15,648,000	-$47,957,533	-75%	30 Jun 2024	10-Q	12 Sep 2024	2024	Q2
Q1 2024	$16,316,000	-$159,359,915	-91%	31 Mar 2024	10-Q	20 May 2024	2024	Q1
Q4 2023	$16,481,000	+$151,000	+0.92%	31 Dec 2023	10-K	08 Oct 2025	2024	FY
Q3 2023	$25,198,000	-$148,678,041	-86%	30 Sep 2023	10-Q	14 Nov 2023	2023	Q3
Q2 2023	$63,605,533	-$110,032,569	-63%	30 Jun 2023	10-Q	14 Aug 2023	2023	Q2
Q1 2023	$175,675,915	+$1,872,211	+1.1%	31 Mar 2023	10-Q	15 May 2023	2023	Q1
Q4 2022	$16,330,000	-$157,861,383	-91%	31 Dec 2022	10-K	16 Apr 2024	2023	FY
Q3 2022	$173,876,041	-$607,283	-0.35%	30 Sep 2022	10-Q	14 Nov 2022	2022	Q3
Q2 2022	$173,638,102	-$1,097,091	-0.63%	30 Jun 2022	10-Q	15 Aug 2022	2022	Q2
Q1 2022	$173,803,704	+$173,524,177	+62078%	31 Mar 2022	10-Q	16 May 2022	2022	Q1
Q4 2021	$174,191,383			31 Dec 2021	10-K	31 Mar 2023	2022	FY
Q3 2021	$174,483,324			30 Sep 2021	10-Q/A	31 Jan 2022	2021	Q3
Q2 2021	$174,735,193			30 Jun 2021	10-Q/A	31 Jan 2022	2021	Q3
Q1 2021	$279,527			31 Mar 2021	10-Q	02 Jul 2021	2021	Q1

* An asterisk sign (*) next to the value indicates that the value is likely invalid.